dr. Renate De Smedt

Journal Article
A1
open access

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma

Stien De Coninck (UGent) , Renate De Smedt (UGent) , Béatrice Lintermans (UGent) , Lindy Reunes (UGent) , Hansen J. Kosasih, Alexandra Reekmans (UGent) , Lauren M. Brown, Nadine Van Roy (UGent) , Bruno Palhais (UGent) , Juliette Roels (UGent) , et al.

(2024) HAEMATOLOGICA. 109(5). p.1373-1384

Add to list

Journal Article
A1
open access

Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma

Lien Provez, Tom Putteman (UGent) , Mattias Landfors, Juliette Roels (UGent) , Lindy Reunes (UGent) , Sara T'Sas (UGent) , Wouter Van Loocke (UGent) , Béatrice Lintermans (UGent) , Stien De Coninck (UGent) , Morgan Thenoz, et al.

(2023) CANCERS. 15(3).

Add to list

Journal Article
A1
open access

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA. 107(6). p.1448-1453

Add to list

PhD Thesis
open access

Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia

Renate De Smedt (UGent)

(2020)

Add to list

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Julie Morscio (UGent) , Lindy Reunes (UGent) , Juliette Roels (UGent) , Valentina Bardelli, Béatrice Lintermans (UGent) , Wouter Van Loocke (UGent) , Afonso Almeida, Laurence C. Cheung, Rishi S. Kotecha, et al.

(2020) BLOOD. 135(19). p.1685-1695

Add to list

Targeting steroid resistance in T-cell acute lymphoblastic leukemia

Renate De Smedt (UGent) , Julie Morscio (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2019) BLOOD REVIEWS. 38.

Add to list

Journal Article
A1
open access

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Sofie Peirs (UGent) , Julie Morscio (UGent) , Filip Matthijssens (UGent) , Juliette Roels (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , Steven Goossens (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , et al.

(2018) HAEMATOLOGICA. 104(1). p.e17-e20

Academic Bibliography

dr. Renate De Smedt

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma

Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

Targeting steroid resistance in T-cell acute lymphoblastic leukemia

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Contents

Support

Contact